Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 43/72 ]
NYSE | Common Stock
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.
It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments.
The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings.
It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services.
The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets.
The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 1, 24 | 3.42 Increased by +0.29% | 3.33 Increased by +2.70% |
| May 2, 24 | 3.21 Increased by +3.88% | 3.07 Increased by +4.56% |
| Feb 22, 24 | 3.38 Decreased by -3.98% | 3.26 Increased by +3.68% |
| Nov 2, 23 | 3.64 Increased by +11.31% | 3.27 Increased by +11.31% |
| Aug 3, 23 | 3.41 Increased by +0.59% | 3.21 Increased by +6.23% |
| May 4, 23 | 3.09 Increased by +7.29% | 2.97 Increased by +4.04% |
| Feb 23, 23 | 3.52 Decreased by -2.22% | 3.44 Increased by +2.33% |
| Oct 27, 22 | 3.27 Decreased by -6.84% | 3.11 Increased by +5.14% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 746.39 M Increased by +8.68% | 137.14 M Increased by +34.59% | Increased by +18.37% Increased by +23.84% |
| Jun 30, 23 | 743.26 M Increased by +5.50% | 111.33 M Increased by +5.52% | Increased by +14.98% Increased by +0.02% |
| Mar 31, 23 | 710.93 M Increased by +10.79% | 76.75 M Decreased by -0.51% | Increased by +10.80% Decreased by -10.20% |
| Dec 31, 22 | 758.00 M Decreased by -0.51% | 78.59 M Decreased by -38.64% | Increased by +10.37% Decreased by -38.32% |
| Sep 30, 22 | 686.79 M Decreased by -1.92% | 101.89 M Decreased by -48.84% | Increased by +14.84% Decreased by -47.84% |
| Jun 30, 22 | 704.54 M Decreased by -1.25% | 105.51 M Increased by +26.75% | Increased by +14.98% Increased by +28.35% |
| Mar 31, 22 | 641.72 M Increased by +1.23% | 77.14 M Increased by +3.04% | Increased by +12.02% Increased by +1.79% |
| Dec 31, 21 | 761.91 M Increased by +7.13% | 128.08 M Increased by +68.24% | Increased by +16.81% Increased by +57.03% |